![Incidence of adverse drug reactions in COVID-19 hospitalised patients through the minimum basic data set - ILAPHAR | Revista de la OFIL Incidence of adverse drug reactions in COVID-19 hospitalised patients through the minimum basic data set - ILAPHAR | Revista de la OFIL](https://www.ilaphar.org/wp-content/uploads/2021/11/Captura-de-pantalla-2021-11-08-a-las-17.32.04.png)
Incidence of adverse drug reactions in COVID-19 hospitalised patients through the minimum basic data set - ILAPHAR | Revista de la OFIL
![Incidence of adverse drug reactions in COVID-19 hospitalised patients through the minimum basic data set - ILAPHAR | Revista de la OFIL Incidence of adverse drug reactions in COVID-19 hospitalised patients through the minimum basic data set - ILAPHAR | Revista de la OFIL](https://www.ilaphar.org/wp-content/uploads/2021/11/Captura-de-pantalla-2021-11-08-a-las-17.31.31.png)
Incidence of adverse drug reactions in COVID-19 hospitalised patients through the minimum basic data set - ILAPHAR | Revista de la OFIL
![Incidence of adverse drug reactions in COVID-19 hospitalised patients through the minimum basic data set - ILAPHAR | Revista de la OFIL Incidence of adverse drug reactions in COVID-19 hospitalised patients through the minimum basic data set - ILAPHAR | Revista de la OFIL](https://www.ilaphar.org/wp-content/uploads/2021/11/Captura-de-pantalla-2021-11-08-a-las-17.31.41.png)